HCi VioCare Appoints William Spence to Advisory Board

Omed, Inc., formerly Optecmed, Inc., is focused on disruptive technologies in the fields of digital health, prosthetics, orthotics, diabetes, assistive devices, sports and wellbeing, and deep vein thrombosis (DVT). It has developed sensing technology under the brand name Flexisense, which uses a multitude of micro sensors to detect pressure as well as shear. It is also focusing on the fields of prosthetics and orthotics (P&O) and diabetic foot clinics in Europe. It holds a wholesale license for medicinal products for human use through C-Pharm, Ltd. It trades pharmaceutical products to wholesalers and manufacturers around the world. It also supplies medical consumables to cruise ships and merchant vessels. Its subsidiaries include C-Pharm, Ltd., HCi Viocare Technologies Limited and HCi Viocare Clinics UK Limited. Its HCi Viocare Technologies is developing hardware solutions focusing on providing on demand information in the fields of digital health, prosthetics, orthotics and DVT.